Tetra-O-acetyl-6-O-trityl-b-D-galactopyranose, CAS:124648-92-6

1,2,3,4-Tetra-O-acetyl-6-O-trityl-b-D-galactopyranose, or TATG, is a chemical compound that belongs to the family of acetate-protected monosaccharides. It is commonly used in synthetic chemistry for the preparation of complex oligosaccharides, especially those that contain galactose or N-acylated glucosamine residues. TATG is also an important intermediate for the synthesis of bioactive molecules such as glycopeptides and glycolipids. Synthesis and Characterization: TATG can be synthesized by the acetylation and tritylation of commercially available D-galactose. The compound can be characterized by various spectroscopic techniques such as nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry. Analytical Methods: TATG can be analyzed using various techniques such as high-performance liquid chromatography (HPLC) and thin-layer chromatography (TLC). Biological Properties: TATG has been shown to exhibit antibacterial and antifungal activity. It has also been studied for its potential anticancer properties. However, more research is needed to determine its mechanism of action. Toxicity and Safety in Scientific Experiments: TATG has been shown to have low toxicity and is generally safe to use in scientific experiments. However, caution must be taken as with any chemical compound. Applications in Scientific Experiments: TATG has a wide range of applications in synthetic chemistry. It is commonly used in the preparation of complex oligosaccharides for biological and biomedical research. It has also been used in the synthesis of various bioactive molecules including glycopeptides and glycolipids. Current State of Research: TATG continues to be an important intermediate in the synthesis of complex molecules. Recent research has focused on its biological properties and its potential use in the development of new drugs. Potential Implications in Various Fields of Research and Industry: TATG has potential implications in various fields including drug discovery, materials science, and biochemistry. Its applications can be extended to the development of new vaccines, drug delivery systems, and biomaterials. Limitations and Future Directions: While TATG has been extensively studied, there are still limitations to its use. One of the major limitations is its cost, which can be prohibitive for large-scale synthesis. Future research should focus on developing more cost-effective methods to synthesize TATG . Another limitation is its limited use in vivo due to its poor solubility and bioavailability. Future directions can include the development of prodrugs and other derivatives with improved solubility and bioavailability. Additionally, more research is needed to fully understand the mechanism of action of TATG and its potential for therapeutic applications. - Development of new synthesis methods for TATG and its derivatives. - Investigation of its mechanism of action in biological systems. - Optimization of TATG derivatives for improved solubility and bioavailability. - Exploration of TATG in drug delivery systems. - Expansion of TATG applications in materials science and biomaterials. CAS Number 124648-92-6 Product Name 1,2,3,4-Tetra-O-acetyl-6-O-trityl-b-D-galactopyranose IUPAC Name [(2R,3S,4S,5R,6S)-4,5,6-triacetyloxy-2-(trityloxymethyl)oxan-3-yl] acetate Molecular Formula C33H34O10 Molecular Weight 590.62 g/mol InChI InChI=1S/C33H34O10/c1-21(34)39-29-28(43-32(42-24(4)37)31(41-23(3)36)30(29)40-22(2)35)20-38-33(25-14-8-5-9-15-25,26-16-10-6-11-17-26)27-18-12-7-13-19-27/h5-19,28-32H,20H2,1-4H3/t28-,29+,30+,31-,32-/m1/s1 InChI Key GTJGUFOLNHYRQE-UNKWROQRSA-N SMILES CC(=O)OC1C(OC(C(C1OC(=O)C)OC(=O)C)OC(=O)C)COC(C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4 Canonical SMILES CC(=O)OC1C(OC(C(C1OC(=O)C)OC(=O)C)OC(=O)C)COC(C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4 Isomeric SMILES CC(=O)O[C@H]1[C@H](O[C@H]([C@@H]([C@H]1OC(=O)C)OC(=O)C)OC(=O)C)COC(C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4 CAS No: 124648-92-6 MDL No: MFCD08703917 Chemical Formula: C33H34O10 Molecular Weight: 590.62